AI 摘要
我们查看了 fasenra specialty pharmacy sourcing 的 1948 个实时结果，并筛选出最值得先比较的 3 个选项。
这份短名单里最突出的主题是 Specialty Pharmacy 和 Hospital Services。
Compare with TopFind
实时搜索
正在加载实时结果
TopFind 正在为你的搜索抓取最新匹配结果。
实时搜索
TopFind 正在为你的搜索抓取最新匹配结果。
我们查看了 fasenra specialty pharmacy sourcing 的 1948 个实时结果，并筛选出最值得先比较的 3 个选项。
这份短名单里最突出的主题是 Specialty Pharmacy 和 Hospital Services。
来源: Specialty Healthcare Providers (Philippines)
描述
Specialized sourcing and administration services for Fasenra (benralizumab) within high-tier medical facilities. These providers ensure the necessary cold-chain logistics (2°C to 8°C) required to maintain the efficacy of biologic medications and provide professional clinical administration for subcutaneous injections.
适用场景
Cold Chain medication management, Hospital Based administration, Verified biologic sourcing 和 Patients at major medical centers
评分
来源: AstraZeneca Pharmaceuticals (Phils.), Inc.
描述
Fasenra is a prescription biologic medication used as an add-on maintenance treatment for adults and children aged 6 years and older with severe eosinophilic asthma. As a monoclonal antibody, it targets and removes eosinophils, a type of white blood cell that causes lung inflammation. It is administered via subcutaneous injection, typically every 4 weeks for the first three doses and every 8 weeks thereafter, using a single-dose pre-filled syringe or the Fasenra Pen autoinjector.
适用场景
Severe eosinophilic asthma patients, Biologic maintenance therapy, Long Term asthma control 和 Pediatric and adult patients
评分
来源: AstraZeneca Malaysia
描述
Fasenra (Benralizumab) is an immunomodulatory biologic available in a 30mg pre-filled pen, typically used for severe eosinophilic asthma.
适用场景
Severe asthma, Eosinophilic conditions 和 Monoclonal antibody therapy
评分
| 比较 | Fasenra Specialty Pharmacy Sourcing | Fasenra (benralizumab) | Fasenra |
|---|---|---|---|
| 来源 | Specialty Healthcare Providers (Philippines) | AstraZeneca Pharmaceuticals (Phils.), Inc. | AstraZeneca Malaysia |
| 描述 | Specialized sourcing and administration services for Fasenra (benralizumab) within high-tier medical facilities. These providers ensure the necessary cold-chain logistics (2°C to 8°C) required to maintain the efficacy of biologic medications and provide professional clinical administration for subcutaneous injections. | Fasenra is a prescription biologic medication used as an add-on maintenance treatment for adults and children aged 6 years and older with severe eosinophilic asthma. As a monoclonal antibody, it targets and removes eosinophils, a type of white blood cell that causes lung inflammation. It is administered via subcutaneous injection, typically every 4 weeks for the first three doses and every 8 weeks thereafter, using a single-dose pre-filled syringe or the Fasenra Pen autoinjector. | Fasenra (Benralizumab) is an immunomodulatory biologic available in a 30mg pre-filled pen, typically used for severe eosinophilic asthma. |
| 适用场景 | Cold Chain medication management, Hospital Based administration, Verified biologic sourcing 和 Patients at major medical centers | Severe eosinophilic asthma patients, Biologic maintenance therapy, Long Term asthma control 和 Pediatric and adult patients | Severe asthma, Eosinophilic conditions 和 Monoclonal antibody therapy |
| 操作 | |||
| 评分 |
如果你想先看最均衡的选择，我推荐：
"Fasenra Specialty Pharmacy Sourcing 来自 Specialty Healthcare Providers (Philippines)."
我选择它是因为 Sourcing through specialized hospital channels ensures that the medication is handled under strict cold-chain requirements and administered by trained healthcare professionals.